HomeProductsBuilding BlocksOrganic Building BlocksBenzene CompoundsBexarotene
Chemical structure of CAS 153559-49-0

Bexarotene

In Stock•Starting at $8 for 1 mg•Purity ≥ 95%
CAS No.153559-49-0
MDL No.MFCD00932428
MFC24H28O2
MW348.50
InChI KeyNAVMQTYZDKMPEU-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg95%$8In Stock
10 mg95%$18In Stock
50 mg95%$22In Stock
250 mg98%$80In Stock
1 g98%$243In Stock
5 g98%$934In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Bexarotene is a retinoid, a benzoic acid derivative and a naphthalene derivative, with antineoplastic activity.

CAS No.153559-49-0
Product NameBexarotene

Biological Targets

RXRB·RXRG·RXRA

Associated Conditions

psoriasis·alopecia areata·leukemia·schizophrenia·lymphoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.

The oncologist • Vol. 6, Issue 1 • 2001
PMID: 11161223DOI: 10.1634/theoncologist.6-1-4

Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.

Biochemical and biophysical research communications • Vol. 280, Issue 3 • 2001
PMID: 11162570DOI: 10.1006/bbrc.2000.4172

Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo.

Circulation research • Vol. 88, Issue 4 • 2001
PMID: 11230116DOI: 10.1161/01.res.88.4.e38

T-cell lymphoma products.

The Nurse practitioner • Vol. 26, Issue 3 • 2001
PMID: 11270155DOI: 10.1097/00006205-200103000-00005

Documentation

Similar Products